Trials / Recruiting
RecruitingNCT05640232
Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea
A National, Multicenter, Randomized, Double-blind, Double-dummy, Phase III, Crossover Study to Assess the Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 238 (estimated)
- Sponsor
- EMS · Industry
- Sex
- Female
- Age
- 16 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study if to evaluate the efficacy and safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CDE100 association | Experimental drug. |
| DRUG | Buscopan® Composto association | Active comparator. |
Timeline
- Start date
- 2025-06-11
- Primary completion
- 2026-06-28
- Completion
- 2027-01-30
- First posted
- 2022-12-07
- Last updated
- 2025-12-08
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05640232. Inclusion in this directory is not an endorsement.